Loading news...
Avalon GloboCare Corp. (NASDAQ: ALBT - Get Free Report) was the target of a significant growth in short interest in February. As of February 13th, there was short interest totaling 133,008 shares, a growth of 31.3% from the January 29th total of 101,273 shares. Approximately 3.5% of the company's stock are short sold. Based on an
U.S. stock futures fell sharply on Monday following Friday's losses. Futures of the major benchmark indices were negative amid the ongoing Iran-U.S. conflict.
$3.25 Million Upfront With up to Approximately $6.5 Million of Potential Aggregate Proceeds Upon the Exercise in Full of Warrants $3.25 Million Upfront With up to Approximately $6.5 Million of Potential Aggregate Proceeds Upon the Exercise in Full of Warrants
$3.25 Million Upfront With up to Approximately $6.5 Million of Potential Aggregate Proceeds Upon the Exercise in Full of Warrants $3.25 Million Upfront With up to Approximately $6.5 Million of Potential Aggregate Proceeds Upon the Exercise in Full of Warrants
Shares of Avalon GloboCare Corp (NASDAQ: ALBT) are trading sharply higher Thursday morning after Benzinga exclusively reported that the company joined Advanced Micro Devices Inc's (NASDAQ: AMD) AI Developer Program.
The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.
Avalon GloboCare Corp (NASDAQ: ALBT) stock is trading lower on Wednesday. Apparently, there is no news to justify the movement.
Fortrea (NASDAQ: FTRE - Get Free Report) and Avalon GloboCare (NASDAQ: ALBT - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings. Earnings and Valuation This table compares Fortrea and
FREEHOLD, N.J., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer products and the advancement of intellectual property in cellular therapy and generative AI publishing and software, today announced that it received notice from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with the Nasdaq Capital Market's minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b). Nasdaq further confirmed that the Company is now in compliance with all applicable continued listing standards.
Greenwich LifeSciences (NASDAQ: GLSI - Get Free Report) and Avalon GloboCare (NASDAQ: ALBT - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability and valuation. Profitability This table compares Greenwich LifeSciences and
4:15pm: That's a wrap on 2025 Stocks wrapped up 2025 with a modest selloff on Wednesday, but the losses did little to overshadow a strong year for the...
4:05pm: Stocks lower on Fed meeting minutes US stocks edged lower following the release of the minutes from the Fed’s latest meeting, which showed officials...
FREEHOLD, N.J., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that Michael Mathews, a member of the Company's Board of Directors and Chief Executive Officer of RPM Interactive, Inc. (“RPM”), participated in an interview with Proactiveinvestors.com. Recently, the Company announced that it has acquired RPM Interactive, Inc. (“RPM”), a generative artificial intelligence (“AI”) publishing and software company.
It’s been a strong year for US stocks, with the top-performing S&P 500 companies delivering remarkable gains fueled by AI-driven demand, commodity surges,...
Shares in Invinity Energy Systems PLC (AIM:IES, OTCQX:IESVF, AQSE:IES) rose 4% to 19.18p after the group announced the first commercial order for its...
Avalon GloboCare Corp. (NASDAQ: ALBT - Get Free Report) was the target of a large increase in short interest in December. As of December 15th, there was short interest totaling 80,987 shares, an increase of 41.2% from the November 30th total of 57,363 shares. Currently, 2.1% of the shares of the stock are sold short. Based
1:00pm: Happy holidays! Wall Street closed out a strong session on Tuesday as stocks extended their holiday rally, with the Dow leading the charge. The...
Nike Inc (NYSE:NKE, XETRA:NKE) shares moved higher before Wednesday’s opening bell on the news that board member Tim Cook purchased 50,000 shares of the...
NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- E.F. Hutton & Co., a leading investment bank providing strategic advisory and capital markets services, today is proud to have served as exclusive financial advisor to RPM Interactive, Inc. (“RPM”) in its acquisition by Avalon GloboCare Corp. (NASDAQ: ALBT). The transaction, completed as an all-stock merger, represents a significant strategic milestone for RPM and underscores E.F. Hutton's continued leadership in advising innovative, high-growth companies across technology and artificial intelligence sectors.
NEW BRUNSWICK, N.J., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Myseum, Inc. (Nasdaq: MYSE) (“Myseum” or the “Company”) today announced the completion of the sale of its approximately 34% ownership interest in RPM Interactive, Inc. (“RPM”) as part of a 100% acquisition of RPM by Avalon GloboCare Corp. (Nasdaq: ALBT) (“Avalon”).